Finance

Beta
Lists
GDRX:NASDAQ
Goodrx Holdings Inc
$2.70
+2.85%
(+0.075) 1D
Jun 9, 10:23:41 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GDRX...
Open
$2.67
High
$2.78
Low
$2.66
Mkt. cap
921.20M
Avg. vol.
1.81M
Volume
528.03K
P/E ratio
28.18
52-wk high
$5.81
52-wk low
$1.77
EPS
$0.10
Beta
1.61
Shares outstanding
104.71M
No. of employees
697
Open
$2.67
High
$2.78
Low
$2.66
Mkt. cap
921.20M
Avg. vol.
1.81M
Volume
528.03K
P/E ratio
28.18
52-wk high
$5.81
52-wk low
$1.77
EPS
$0.10
Beta
1.61
Shares outstanding
104.71M
No. of employees
697
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to GDRX in the past 3 months
Buy
Buy
4
Hold
2
Sell
1
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for GDRX in the last 3 months.
Highest
Current $2.70
$4.00 (+47.87%)
Average
$3.60 (+33.09%)
Lowest
$3.00 (+10.91%)
News stories
From sources across the web
About Goodrx Holdings Inc
CEO-
Employees697
Founded2011
HeadquartersSanta Monica, California, United States
SectorHealth care
Websitegoodrx.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.07 / $0.07
-2.18%miss
Revenue / Est. (USD)
194.01M / 185.41M
+4.64%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
203.07M
196.03M
194.78M
194.01M
Cost of goods sold
13.35M
13.42M
17.46M
20.16M
Cost of revenue
13.35M
13.42M
17.46M
20.16M
Research and development expenses
29.93M
31.01M
25.24M
30.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
113.25M
115.55M
91.96M
107.87M
Operating expense
162.91M
167.99M
140.34M
159.84M
Total operating expenses
176.26M
181.41M
157.81M
180.00M
Operating income
26.81M
14.62M
36.98M
14.01M
Other non operating income
694.00K
-
24.00K
-
EBT including unusual items
19.58M
6.10M
14.19M
5.64M
EBT excluding unusual items
19.58M
6.10M
28.49M
5.64M
Income tax expense
6.73M
4.98M
8.77M
4.47M
Effective tax rate
34.40%
81.66%
61.78%
79.27%
Other operating expenses
-
-
-
-
Net income
12.84M
1.12M
5.42M
1.17M
Net profit margin
6.32%
0.57%
2.79%
0.60%
Earnings per share
0.09
0.08
0.09
0.07
Interest and investment income
2.80M
2.31M
1.89M
1.40M
Interest expense
-10.73M
-10.83M
-10.40M
-9.77M
Net interest expenses
-7.93M
-8.52M
-8.51M
-8.37M
Depreciation and amortization charges
19.73M
21.43M
23.15M
21.79M
EBITDA
46.54M
36.05M
60.12M
35.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more